Serum deprived v-mos-transformed NIH3T3 cells are unable to enter a true quiescent state, but instead, arrest in the early G1 phase of the cell cycle. We have analysed several cell cycle regulatory proteins in these G1 arrested cells and show altered regulation in the expression and activity of certain cyclins and cyclin-dependent kinases. In particular, p34 , and p34
Serum deprived v-mos-transformed NIH3T3 cells are unable to enter a true quiescent state, but instead, arrest in the early G1 phase of the cell cycle. We have analysed several cell cycle regulatory proteins in these G1 arrested cells and show altered regulation in the expression and activity of certain cyclins and cyclin-dependent kinases. In particular, p34 cdc2 , cyclin A, cyclin D and cyclin E are not appropriately down-regulated in serum starved, G1 arrested, v-mos-transformed cells as compared with quiescent NIH3T3 cells. Furthermore, serum starved vmos-transformed cells have elevated histone H1 kinase activity associated with cyclin A, cyclin E, p33
cdk2
, and p34
cdc2 . Using a metallothionein-inducible c-mos mu expression system, we show that c-mos mu induction in quiescent NIH3T3 cells causes elevated expression of p34 cdc2 . However, this induction of c-mos mu and subsequent expression of p34 cdc2 was not sucient to promote signi®cant entry of cells into S phase. Analysis of extracts from serum starved v-H-ras, v-src, and tpr-met transformed NIH3T3 cells demonstrates that these oncogene-transformed cells also contain elevated levels of p34 cdc2 . We propose that the altered regulation of these
Introduction
The v-mos gene of the Moloney murine sarcoma virus (Mo-MSV) encodes a cytoplasmic serine/theonine protein kinase that causes ®brosarcomas in mice and transforms ®broblasts in culture (Canaani et al., 1979; Maxwell and Arlinghaus, 1985) . Its cellular homolog, c-mos, is also capable of transforming ®broblasts when placed under the control of long terminal repeat (LTR) sequences of Mo-MSV (Blair et al., 1981; Oskarsson et al., 1980) . Relatively high levels of c-mos mRNA expression have been found in germ cells from a variety of vertebrates while much lower levels of expression have been detected in some somatic tissues (Goldman et al., 1987; Herzog et al., 1988 Herzog et al., , 1989 Keshet et al., 1988; Li et al., 1993; Mutter and Wolgemuth, 1987; Propst et al., 1987; Propst and Vande Woude, 1985; Sagata et al., 1988; Tsui et al., 1993) . Mos has been shown to have a critical role in oocyte maturation as demonstrated by the phenotype of mos de®cient (knockout) mice (Colledge et al., 1994; Hashimoto et al., 1994) . These mice are viable and, while males are fertile, females have a reduced fertility because of the inability of mature eggs to arrest appropriately during meiosis. It has been shown that mos is a potent activator of the mitogen-activated protein (MAP) kinase pathway in oocytes and also in somatic cells if inappropriately expressed (Nebreda and Hunt, 1993; Posada et al., 1993) . The MAP kinase pathway is a highly conserved network of protein kinases involved in the transduction of extracellular signals ultimately leading to changes in gene expression (Cobb et al., 1991; Thomas, 1992) . A number of other proto-oncogenes and their oncogenic counterparts, such as ras, raf and src, are also known to activate the MAP kinase pathway. MAP kinase(s) is (are) activated by dual phosphorylation of theonine and tyrosine residues by MAP kinase kinase(s) [MEK(s) ]. Mos is able to activate the MAP kinase pathway by directly activating MEK though phosphorylation on critical serine residues within its catalytic domain leading to the subsequent activation of MAP kinase (Resing et al., 1995) . Constitutively activated MEK is able to induce transformation in murine ®broblasts (Cowley et al., 1994; Mansour et al., 1994) .
The MAP kinase pathway is normally activated by growth factors in cells exiting quiescence (G0) and reentering the cell cycle or undergoing dierentiation. Re-entry into the cell cycle from quiescence requires a complex series of biochemical events driven by the synthesis and assembly of cell cycle regulatory proteins such as the G1 cyclins and cyclin-dependent kinases. Forced overexpression of G1 cyclins can shorten the G1 phase of the cell cycle and lead to an earlier entry into DNA synthesis (Quelle et al., 1993; Resnitzky et al., 1994) . We have previously shown that v-mostransformed cells are unable to enter a true quiescent state in the complete absence of serum and enter DNA synthesis sooner than nontransformed cells upon serum stimulation (Rhodes et al., 1994) . Since Mos expression during the G1 phase of the cell cycle has been shown to be an important step in mos-induced transformation (Okazaki et al., 1992) , we investigated how mos disrupts G1 control by analysing several cell cycle regulatory proteins that are important for progression through the cell cycle. We found that serum starved, G1-arrested v-mos-transformed cells are unable to fully downregulate cyclins A, D1 and E when compared to serum starved, quiescent NIH3T3 cells. Furthermore, serum starved v-mos-transformed cells have elevated levels of p34 cdc2 at both the mRNA and protein levels, and increased in vitro histone H1 kinase activity associated with p34
, cyclin A, and cyclin E. The expression and activity of these cyclins and cdks appears to be similar for the v-mos-transformed and nontransformed NIH3T3 cells during exponential growth, with dierences evident only after complete serum withdrawal. Forced expression of c-mos mu in quiescent cells under the regulation of an inducible metallothionein promoter causes induction of p34 cdc2 , demonstrating that the inability of mos transformed NIH3T3 cells to fully downregulate p34 cdc2 following serum withdrawal is a direct consequence of mos expression. We have also analysed cell lines transformed with v-H-ras, v-src, and tpr-met oncogenes and detect elevated levels of p34 cdc2 after serum starvation. This altered expression and activity of critical cell cycle regulatory proteins in the absence of mitogenic stimuli may represent a critical step in the process of neoplastic transformation
Results

Analysis of cell cycle regulatory proteins in v-mostransformed cells after release from serum starvation
The transition from the G1 to S phase in higher eukaryotes requires the synthesis and activity of several cell division kinase complexes (Pines, 1993; . We have previously shown that v-mos-transformed cells are unable to enter quiescence but arrest in the early G1 phase of the cell cycle in response to complete serum deprivation (Rhodes et al., 1994) . In addition to the inability of serum starved v-mostransformed cells to enter a true quiescent state, the re-addition of serum resulted in an earlier entry into DNA synthesis for the v-mos-transformed cells when compared to nontransformed NIH3T3 cells (Rhodes et al., 1994 ) (see also Figure 1a ). We have also found that the earlier entry into S phase was independent of the duration of the serum starvation because v-mostransformed cells serum starved for 72 h also enter S phase 2 ± 4 h earlier than the parental NIH3T3 cells (data not shown). To investigate a molecular basis for the lack of quiescence and early entry into DNA synthesis, the levels and activity of several key proteins involved in regulating cell cycle transitions were determined. We initially examined the eects of v-mos transformation on the timing and accumulation of cyclins A, B, D, and E and two of their regulatory partners, p34 cdc2 and p33 cdk2 . NIH3T3 and 121mos cells were serum starved for 48 h and whole cell extracts were prepared every 2 h after the addition of medium containing 10% calf serum. Cells from duplicate plates were analysed bȳ ow cytometry to correlate cellular DNA content and hence progression through the cell cycle with time after release from serum starvation (Figure 1a) . In agreement with previous reports, both cell lines arrested primarily with a G0/G1 DNA content and the 121mos cells re-entered the cell cycle earlier than the parental NIH3T3 cells (Figure 1a ; Rhodes et al., 1994) .
Whole cell extracts were analysed for p34 cdc2 expression by immunoblot analysis (Figure 1b) . Previous studies have shown that quiescence induced by contact inhibition or serum withdrawal in fibroblasts leads to a reduction of cellular levels of the p34 cdc2 protein kinase (Lee et al., 1988; Morla et al., 1989) . As expected, p34 cdc2 protein levels were very low in serum starved NIH3T3 cell extracts and increased throughout G1 (Figure 1b , 0 ± 12 h), followed by phosphorylation and the resulting decrease in electrophoretic mobility as cells entered S phase (Figure 1b (Figure 1b , *18 ± 20 h). Thus, it appears that transformation by v-mos did not signi®cantly alter the de novo phosphorylation of p34 cdc2 as cells entered and progressed through the cell cycle, but did aect the relative abundance of p34 cdc2 after serum starvation. Analysis of these same extracts for p33 cdk2 using a p33 cdk2 C-terminal speci®c antibody showed similar levels of protein throughout the cell cycle for both the v-mos-transformed cells and NIH3T3 cells (Figure 1c) .
We also examined the expression of cyclin proteins that are known to associate with p34 cdc2 and p33 cdk2 . Analysis of cyclin B1 from serum stimulated NIH3T3 extracts using a monoclonal antibody against human cyclin B1, which cross reacts with mouse cyclin B, showed an accumulation of a 62 kDa protein at a time coincident with the cells being in G2 (Figure 1d , 18 ± 20 h) and a rapid decline of this protein as the cells entered mitosis (Figure 1d, 20 ± 22 h) . This is consistent with the periodicity previously reported with cyclin B levels (Minshull et al., 1989) . The level of cyclin B1 protein in the v-mos-transformed cells also rose as the cells reached G2 (Figure 1d , 16 ± 18 h), and declined as the cells progressed through mitosis (Figure 1d , 18 ± 20 h). We were unable to detect signi®cant expression of cyclin B1 protein in the serum starved v-mostransformed cell extracts (Figure 1d , 0 h).
Both p34 cdc2 and p33 cdk2 associate with cyclin A to form active kinase complexes Marraccino et al., 1992; Minshull et al., 1990; Pines and Hunter, 1990) . These complexes have been reported to be important for progression through S phase (for cyclin A/p33 cdk2 ) as well as through the G2/ M transition (for cyclin A/p34 cdc2 ) (Girard et al., 1991; Pagano et al., 1992; Zindy et al., 1992) . Immunoblot analysis of cyclin A expression in NIH3T3 cells that had been serum starved for 48 h showed the appearance of cyclin A protein 12 h after serum stimulation (Figure 1e , 12 h), corresponding to late G1/early S phase. Cyclin A levels persisted at relatively high levels throughout S and G2 and decreased as the cells proceeded through mitosis (Figure 1e , 22 ± 24 h), in agreement with previously published reports (Minshull et al., 1990; Pines and Hunter, 1990) . In marked contrast to the parental NIH3T3 cell, cyclin A was present in v-mos-transformed cells after 48 h of serum starvation (Figure 1e Previous reports demonstrate that p33 cdk2 associates predominantly with cyclin E, but also forms complexes with cyclin A and certain of the D-type cyclins Elledge et al., 1992; Giordano et al., 1989; Ko et al., 1992; Pines and Hunter, 1990; Rosenblatt et al., 1992; Tsai et al., 1991; Xiong et al., 1992) . We analysed these extracts for cyclin E expression and two major bands (50 kDa and 47 kDa) were detected in serum starved NIH3T3 extracts on immunoblots using cyclin E antiserum ( Figure 1f) . Cyclin E molecules with decreased electrophoretic mobility, presumably representing phosphorylated forms of cyclin E, appeared as the cells entered S phase (Figure 1f , 12 h) corresponding to the time when cyclin E-associated kinase activity is reported to be most active (Ko et al., 1992) . These slower migrating forms of cyclin E diminished as the cells exited S phase and entered G2 (Figure 1f , 18 ± 20 h). Immunoblots of extracts from serum starved vmos-transformed cells, Figure 1f , 0 h, showed the presence of the slower migrating form of cyclin E, similar to the pattern of cyclin E molecules that is observed only later in early S phase NIH3T3 extracts. We still observed an increase in the abundance of this slower migrating form as the 121mos cells enter S phase ( D-type cyclins appear to have a major role in the progression through the G1 phase of the cell cycle . When we analysed these same extracts for cyclin D expression using anti-cyclin D polyclonal antibodies, a 36 kDa protein was evident in NIH3T3 cell extracts 6 ± 8 h after release from serum starvation and reached maximal levels after 12 ± 14 h (Figure 1g ), a result consistent with previous ®ndings using human ®broblasts (Won et al., 1992) . This molecular weight was consistent with the apparent molecular weight of cyclin D1 (Matsushime et al., 1991b; Xiong et al., 1991) , and was subsequently con®rmed to be cyclin D1 using an anti-cyclin D1 monoclonal antibody (data not shown). We also detected a second increase in cyclin D levels as the NIH3T3 cells progressed through G2 (Figure 1g , 18 ± 20 h). In contrast, cyclin D was present in v-mos-transformed cells after 48 h of serum starvation ( Figure 1g , 0 h). The levels of cyclin D protein increased as cells progress through the cell cycle with an intitial peak in late G1, and another peak after the cells had gone through DNA synthesis ( Figure  1g ).
To determine whether the elevated expression of cyclins A, D, E, and p34 cdc2 in the serum starved v-mostransformed cells was in fact due to altered expression in the arrested cells or merely due to expression in a fraction of cells continuing to progress through the cell cycle (17%, see Figure 1a ), double immuno¯uorescence experiments were performed to analyse the levels for one of these cell cycle regulatory proteins, p34 cdc2 , and BrdU incorporation into synthesizing DNA simultaneously. Cells growing on coverslips were serum starved for 48 h and then incubated with BrdU for 2 h in the same starve medium. Exponentially growing NIH3T3 cells were incubated with BrdU for 2 h as a control. Double immuno¯uorescence staining of the exponentially growing NIH3T3 cells with anti-BrdU and anti-p34 cdc2 C-terminal antibodies showed BrdU incorporation in a large proportion of cells, and p34 This clearly demonstrates that the increased levels of p34 cdc2 in the serum starved v-mos-transformed cells, compared to the serum starved NIH3T3 cells, was not due to the 15 ± 17% of cells continuing to cycle.
Inducible expression of murine c-mos (c-mos P2A ) in quiescent NIH3T3 cells results in elevated levels of p34 To determine whether or not the alterations in the expression of cell cycle regulatory proteins in serum starved v-mos transformed cells were indeed a consequence of mos activity, we examined the eects of forced expression of mouse c-mos(P2A) on the levels of p34 cdc2 in serum starved NIH3T3 cells. Expression vectors were constructed such that a mutated murine cmos gene (c-mos P2A) was cloned in both sense and antisense orientations into a zinc-inducible expression vector containing the sheep metallothionein promoter (pMT-CB6+; see Materials and methods). In this particular construct, the proline residue at position +2 has been changed to an alanine to enhance expression levels of protein since it was shown that mutation of the homologous residue confers increased stability to Xenopus mos (Nishizawa et al., 1993) .
These constructs were introduced into NIH3T3 cells and stable transfectants were isolated that expressed mos sense and antisense mRNA in a zinc-inducible manner (Figure 3a) . The induction of sense and antisense c-mos (P2A) mRNA appeared 2 h following zinc addition (100 mM ZnSO 4 ) and was present for up to 24 h in the presence of zinc (Figure 3a) . Furthermore, by both direct Western blot analysis and immunoprecipitation followed by Western blot analysis, expression of mos protein was induced by 6 to 8 h following zinc addition (data not shown). Cells containing c-mos (P2A) in the sense orientation also underwent morphological alterations resembling those cdc2 expression. Exponentially growing NIH3T3 cells (a ± c), serum starved NIH3T3 cells (d ± f), and serum-starved 121mos cells (g ± i) were analysed by triple staining to correlate p34 cdc2 levels with proliferative status. Cells were stained with DAPI to visualize nuclear DNA (a, d, g), anti-BrdU antibody with FITCconjugated secondary antibody (b, e, h), and anti-p34 cdc2 C-terminal antibody with Texas Red-conjugated secondary antibody (c, f, i). Cells were photographed using similar exposure times for each of the three independent stains observed in transformed cells 8 ± 12 h following Zinc addition, whereas cells expressing antisense mos and the control cells did not (data not shown).
To examine the eect of induced mos expression on p34 cdc2 levels, cells containing these constructs were serum starved for 48 h in media containing 0.5% calf serum and then zinc (25 mM ZnSO 4 ) was added for an additional 24 h in media containing 0.2% calf serum. Cells were harvested, the percentage of cells in each phase of the cell cycle was determined by¯ow cytometry, and extracts were prepared and analysed for relative p34 cdc2 levels ( Figure 3b ). As expected, p34 cdc2 is downregulated in the serum starved NIH3T3 cells and in cells expressing antisense c-mos (P2A). However, in cells expressing sense c-mos(P2A), p34 cdc2 was present and existed in multiple phosphorylated states. Interestingly, these cells remained primarily in a G0/G1 arrested state and did not signi®cantly enter DNA synthesis (Figure 3b ). Initial experiments performed using 100 mM ZnSO 4 on serum starved cells were unsuccessful because of signi®cant cell death in all serum starved cell lines tested, irregardless of the vector construct. We found that the addition of 25 mM zinc was able to induce c-mos(P2A) mRNA in serum starved cells without the signi®cant cell death observed when using higher zinc concentrations (data not shown).
Lack of quiescence in serum starved v-mos-transformed cells correlates with elevated cyclin-dependent kinase activity
Mos is known to associate with p34 cdc2 molecules (Zhou et al., 1992) and regulate its activity in meiosis (Daar et al., 1991; Freeman et al., 1990; O'Keefe et al., 1989; Paules et al., 1989; Sagata et al., 1988) . Since we detect elevated levels of p34 cdc2 protein in serum starved vmos-transformed cells and phosphorylated forms of this kinase that are normally present in S and G2 phases, we investigated p34 cdc2 in vitro kinase activity. In vitro kinase assays were performed using protein complexes immunoprecipitated with p34 cdc2 C-terminal speci®c antibodies (Figure 4a ). The p34 cdc2 histone H1 activity was similar for exponentially growing NIH3T3 and v-mos-transformed cells (Figure 4a, lanes 1 and 3) , although we occasionally observe more activity from vmos-transformed cells than from NIH3T3 cells ( Figure  4a, lanes 1 and 3) . This suggests that v-mos does not cdc2 using 10 mg of whole cell extract prepared from exponentially growing cells (log), cells serum starved for 48 h in 0.5% calf serum (ss), or cells serum starved for 48 h in 0.5% calf serum followed by 24 h in 25 mM ZnSO 4 in medium containing 0.2% calf serum (ss ind). Duplicate plates were analysed by¯ow cytometry and the percentage of cells in each phase of the cell cycle is shown Altered cell cycle control in v-mos-transformed cells N Rhodes et al signi®cantly aect this activity in cycling cells, in agreement with previously published results for Xenopus c-mos-transformed NIH3T3 cells (Daar et al., 1991) . After serum starvation, however, the NIH3T3 cells had barely detectable levels of p34 cdc2 kinase activity while the v-mos-transformed cells had somewhat higher levels ( Figure 4a, lanes 2 and 4) . When the levels of histone H1 kinase activity were quantitated by direct phosphorimage analysis of gels, immunoprecipitates from 121mos cells serum starved for 72 h (*3 cell doubling times) had levels of p34 cdc2 histone H1 kinase activity approximately 10 times higher than that of NIH3T3 cells serum starved for 48 h (*3 cell doubling times) (Figure 4a , lanes 2 and 4).
We next examined extracts from serum starved NIH3T3 and 121mos cells for protein levels and in vitro histone H1 kinase activity of p33 cdk2 . By immunoblot analysis, we found no signi®cant difference in the levels of p33 cdk2 present in the extracts from each of the serum starved cell lines (see Figure 1c) . When histone H1 kinase reactions were performed with extracts immunoprecipitated with p33 cdk2 C-terminal speci®c antibodies (Figure 4b ), the activity from serum starved v-mos-transformed cells was approximately three times higher than from serum starved NIH3T3 cells (Figure 4b, lanes 2 and 4) .
The elevated levels of p34 cdc2 protein and increased histone H1 activity, along with the elevated levels of cyclin A in serum starved v-mos-transformed cells, suggested that the elevated p34 cdc2 and p33 cdk2 kinase activity could be due to their association with cyclin A. In vitro histone H1 kinase assays were performed using immunoprecipitates with cyclin A antiserum from exponentially growing and serum starved NIH3T3 and 121mos cells (Figure 5a ). The level of histone H1 kinase activity was similar for exponentially growing NIH3T3 and 121mos cells (Figure 5a, lanes 2 and 5) . However, extracts from 121mos cells serum starved for 72 h showed signi®cantly greater (*24-fold) cyclin Aassociated histone H1 activity than NIH3T3 cells serum starved for 72 h (Figure 5a, lanes 3 and 6) .
Elevated levels of`activated' cyclin E (Figure 1f ) and elevated p33cdk2 kinase activity (Figure 4b ) in serum starved v-mos-transformed cells prompted us to investigate the levels of cyclin E-associated kinase activity in these cels. Histone H1 reactions were subsequently performed using immunoprecipitates with cyclin E antiserum from extracts of exponentially growing and serum starved NIH3T3 and 121mos cells (Figure 5b ). Similar levels of cyclin E-associated kinase activity were detected in exponentially growing parental and v-mos-transformed cells, whereas the activity from v-mos-transformed cells serum starved for 72 h was higher (*threefold) than the activity from NIH3T3 cells serum starved for 48 h (Figure 5b , lanes 2 and 4). Although the cyclin E-associated kinase activity from serum starved 121mos extracts appears to be much higher than the p33 cdk2 kinase activity (compare Figure 4b , lane 4 and Figure 5b , lane 4), the fold elevation over serum starved NIH3T3 cells is similar (*threefold) because of the higher background levels for cyclin E-associated kinase activity in serum starved NIH3T3 cells. Therefore, the elevated p34 cdc2 and p33 cdk2 histone H1 activity in serum starved v-mostransformed cells was due, at least in part, to activated cyclin A and cyclin E/cdk complexes.
Elevated levels of p34
cdc2 protein were accompanied by increased p34 cdc2 mRNA expression in serum starved v-mos-transformed cells
We sought to determine whether the elevated level of p34 cdc2 in serum starved v-mos-transformed cells was due to defective transcriptional regulation of p34 cdc2 mRNA expression. Total cellular RNA was prepared from exponentially growing and serum starved NIH3T3 and 121mos cells. Northern analysis using a murine p34 cdc2 probe showed relatively similar levels of p34 cdc2 message for the exponentially growing NIH3T3 and v-mos-transformed cells, although slightly more (*twofold) steady state p34
cdc2 mRNA was present in the 121mos cells (Figure 6b, lanes 1 and 2) . The level of p34 cdc2 message in the NIH3T3 serum starved cells 
(a)
In vitro histone H1 kinase reactions were performed using anticyclin A immunoprecipitates from extracts (250 mg protein) of NIH3T3 and 121mos cells exponentially growing (log) or serum starved for 72 h. Immunoprecipitations were performed with 5 ml anti-cyclin A antiserum or without (No Ab) antiserum as a control. (b) In vitro histone H1 kinase reactions were performed using anticyclin E immunoprecipitates from extracts (250 mg protein) of NIH3T3 and 121mos cells exponentially growing (log) or serum starved for 48 and 72 h, respectively. Immunoprecipitations were performed with 2.5 ml of anti-cyclin E antiserum Altered cell cycle control in v-mos-transformed cells N Rhodes et al was greatly reduced compared to the level in exponentially growing cells (Figure 6b , lanes 1 and 3), as previously reported for quiescent ®broblasts (Welch and Wang, 1992) . The level of p34 cdc2 mRNA in the serum starved v-mos-transformed cells was elevated compared to the level in serum starved NIH3T3 cells (*sevenfold), even though similar amounts of RNA were loaded on the gel (Figure 6b, lanes 3 and 4) . The elevated levels of p34 cdc2 protein in serum starved vmos-transformed cells therefore, seem to be due, at least in part, to the inability to down-regulate the levels of p34 cdc2 mRNA or to stabilize the cdc2 message, although we cannot rule out the possibility that the protein stability of p34 cdc2 is also altered in these cells. p34 cdc2 is not fully downregulated following serum starvation in cell lines transformed with other oncogenes
The previously described experiments were performed using a speci®c v-mos ml cell line (121mos). We were interested in determining whether other mos-transformed cell lines, as well as, cell lines transformed with other oncogenes were also unable to fully downregulate cell cycle regulatory proteins following serum starvation. A second v-mos ml cell line (422mos) and a mass population of v-mos 124 infected NIH3T3 cells (124mos) were used for subsequent analysis, along with a v-Hras, a v-src and a tpr-met transformed NIH3T3 cell line. Whole cell extracts were prepared from exponentially growing and serum starved cells and analysed for p34 cdc2 expression levels, while cells from duplicate plates were ®xed and assayed by¯ow cytometry to determine the percentage of cells in each phase of the cell cycle (Figure 7) . The overall levels of p34 cdc2 were similar in extracts from all of the exponentially growing cell lines, and as expected, p34
cdc2 was fully downregulated in serum starved NIH3T3 cells and present in serum starved 121mos cells. Elevated levels of p34 cdc2 were present in the other v-mos ml transformed cell line (422mos) and both of the v-mos ml cell lines had approximately the same percentage of cells in each phase of the cell cycle following serum starvation. The levels of p34 cdc2 in extracts from serum starved v-mos 124 cells (124mos) were higher than in extracts from the parental NIH3T3 cells but were less elevated compared to the levels in extracts from the v-mos ml transformed cells (121mos and 422mos). The parental NIH3T3 cells and the v-mos 124 cells had very similar percentages of cells in each phase of the cell cycle after serum starvation. Therefore, from these data together with those shown in Figure 3 , we conclude that the inability to downregulate p34 cdc2 in response to serum deprivation is a consequence of mos-expression in ®broblasts.
Elevated levels of p34 cdc2 were also detected in extracts from serum starved v-H-ras, v-src and tprmet transformed cell lines (Figure 7) . These levels were similar to the levels in extracts from the v-mos ml cell lines. In each case, the complete withdrawal of serum for 48 h induced a similar cell cycle arrest in these cell lines, with an increase in the percentage of cells in the G1 phase of the cell cycle and a corresponding decrease in the percentage of cells in S phase after serum starvation of all of the transformed cell lines ( Figure  7 ).
Discussion
We have found that mouse ®broblasts transformed by the v-mos oncogene are unable to fully down-regulate critical cell cycle regulatory proteins in response to complete serum withdrawal, even though these cells are primarily in an arrested state. Speci®cally, serum starved v-mos-transformed cells are unable to appropriately down-regulate the expression of p34 cdc2 , cyclin A, and cyclin D1, and have inappropriately elevated levels of kinase activity associated with p34 cdc2 , p33 cdk2 , cyclin A and cyclin E. We have also observed an inability to fully down-regulate p34 cdc2 in serum starved ®broblasts transformed with v-H-ras, v-src and tpr-met oncogenes. This inability to down-regulate, and the associated elevated catalytic kinase activity of cell cycle cdc2 following serum starvation for other v-mos-transformed cell lines and cell lines transformed with other oncogenes. Whole cell extracts were prepared from exponentially growing cells (log) or cells serum starved in media containing no serum for 48 h (ss). The immunoblot was performed using 10 mg of protein and blotting with anti-p34 cdc2 antibodies. Duplicate plates were analysed bȳ ow cytometry and the percentage of cells in each phase of the cell cycle is shown regulatory proteins in the absence of growth factors could contribute to a growth advantage and subsequently to the transformed phenotype of these cells.
The ampli®cation and overexpression of cyclin genes has been found in a variety of tumors Buckley et al., 1993; Faust and Meeker, 1992; Hinds et al., 1994; Keyomarsi et al., 1994; Keyomarsi and Pardee, 1993; Leach et al., 1993; Motokura and Arnold, 1993; Motokura et al., 1991; Musgrove et al., 1993) . Forced overexpression of cyclin D1 in mammary cells in transgenic mice resulted in mammary adenocarcinomas, suggesting a possible role for this cyclin in breast cancer . Furthermore, in vitro studies have shown that overexpression of cyclin E causes a shortening of the G1 phase of the cell cycle and a reduced cell size . However, these cyclin E-overexpressing cells are not transformed in that they remain serum dependent, contact inhibited, and are unable to form colonies in soft agar. The overexpression of cyclin D1 in rat2 ®broblasts also resulted in accelerated G1 progression and these cells remained contact inhibited and anchorage dependent, and exhibited a reduced serum requirement for growth (Quelle et al., 1993) . Interestingly, forced expression of cyclin A in NRK or NIH3T3 ®broblasts induces anchorage-independent growth (Guadagno et al., 1993) . The lack of downregulation of cyclin A in serum starved v-mostransformed cells may contribute to their ability to form foci and undergo anchorage-independent growth in soft agar. Thus, the overexpression of G1/S cyclins has profound eects on the cell cycle and contributes to the altered growth properties of a transformed cell. In this study, we have demonstrated the altered expression of cyclins in oncogenically transformed cells under conditions where these cyclins should normally be down-regulated.
In Xenopus oocytes both mos and p33 cdk2 , are required for cytostatic factor (CSF) activity, the activity responsible for arresting unfertilized oocytes in metaphase of meiosis II (Gabrielli et al., 1993) . Interestingly, G1 arrested, serum starved v-mostransformed cells display a phenotype that shares some of the characteristics of CSF-arrested oocytes, having elevated levels of p34 cdc2 and p33 cdk2 kinase activities. However, in marked contrast to CSFarrested oocytes, this CSF-like phenotype is being displayed in early G1, at a point where the cells are attempting to exit the cell cycle, instead of M phase. Thus, instead of arresting progression through cycle, the aect is to block exit from proliferation. This result is consistent with evidence demonstrating the necessity for mos expression in the G1 phase of the cell cycle to elicit the full transforming activity of this oncogene (Okazaki et al., 1992) .
In addition to the regulation of the G1/S phase transition by the association of cyclin A and cyclin E with various cdks, another S phase function of cyclin A and cyclin E involves their ability to bind to other proteins, such as the transcription factor E2F and a protein related to the retinoblastoma gene product (pRB), p107 . In fact, serum starved v-mos-transformed cells have E2F complexes that resemble S phase E2F complexes in nontransformed cells and contain both cyclins A and E, p107, and p33 cdk2 (C Afshari and M Mudryj, see pages 3029 ± 3038 of this issue). It has been shown that overexpression of E2F1 can induce quiescent cells to enter S phase (Johnson et al., 1993 (Nebreda and Hunt, 1993; Posada et al., 1993) . This pathway is known to be activated by a variety of external stimuli, such as growth factors, and has been reported to be constitutively activated in cells transformed by several oncogenes, such as src and raf (Gupta et al., 1992; Kyriakis et al., 1992) . One consequence of the activation of this pathway is changes in gene expression mediated through changes in the phosphorylation state of c-fos, which is a component of the AP-1 transcription factor . Furthermore, it has been reported that mos, as well as other oncoproteins that can signal through the MAP kinase pathway (ras and src, for example, but not myc), can cause elevated expression of fos and AP-1 activity (Jehn et al., 1992; Touray et al., 1991) . We have also found that AP-1 complexes are activated in serum starved v-mos-transformed cells, presumably due to constitutive activation of the MAP kinase pathway (Afshari and Mudryj, see pages 3029 ± 3038 of this issue). Inappropriate activation of this MAP kinase pathway by activated ras leads to the increased expression of cyclin D, which is normally induced by external signals (Filmus et al., 1994; Lanahan et al., 1992; Matsushime et al., 1991a; Won et al., 1992) . Since p34 cdc2 and cyclin A have E2F responsive elements (Dalton, 1992; Henglein et al., 1994) , their elevated expression could be a result of altered E2F complexes. This could explain the lack of quiescence in serum starved v-mos-transformed cells with elevated cyclin and cdk activities in an arrested state. At present, we are investigating any possible altered expression or regulation of pRB or p107 and their relationship to the altered activity of E2F in serum starved v-mos-transformed cells. Preliminary results indicate that serum starved v-mos-transformed cells have hyperphosphorylated forms of Rb (N Rhodes and RS Paules, unpublished observation) . This is consistent with the interpretation that the increased levels of cyclin D1 are associated with an increase in the cyclin D-associated phosphorylation of Rb, thereby inactivat- A fundamental characteristic of cancer cells is their inability to respond properly to growth regulatory signals. We have shown that v-mos-transformed cells are unable to respond appropriately to environmentally stressful conditions such as serum withdrawal. The inability to down-regulate the expression and activity of critical cell cycle regulatory proteins under these conditions indicates that the pathways leading to the regulation of these proteins are disrupted by mosinduced transformation, as well as transformation induced by other oncogenes, possibly through constitutive activation of the MAP kinase pathway.
Materials and methods
Cell culture, synchronization, and cell cycle analysis NIH3T3, 121mos, and 422mos cells were grown and synchronized by serum deprivation as described (Rhodes et al., 1994) . The v-mos124 cells were created by retroviral infection of the parental NIH3T3 cells with the 124 strain and were derived from a mass population of surviving cells after retroviral infection (Donoghue and Hunter, 1983) . NIH3T3 ®broblasts overexpressing v-Ha-ras were obtained from L Hansen (Hansen and Tennant, 1994) , v-src transformed ®broblasts were obtained from D Shalloway, and the tpr-met transformed NIH3T3 cell line was obtained from I Daar (personal communication). For serum starvation and cell synchronization, exponentially growing cells were washed twice with phosphate buered saline (PBS) or serum-free Dulbecco's Modi®ed Eagle Medium (DMEM) at 378C and incubated for the indicated times in serum-free DMEM supplemented with L-glutamine. Re-entry into the cell cycle was initiated by replacing the starve medium with medium containing 10% calf serum. For analysis of cellular DNA content by¯ow cytometry, trypsinized cells were ®xed in 67% MeOH/PBS and stored at 48C. Cells were treated with RNase and propidium iodide according to instructions contained in the cellular DNA¯ow cytometric analysis reagent set (Boehringer Mannheim) and analysed using a Becton-Dickinson FACSCAN¯uoresence activated cell scanner. Data acquisition and analysis were performed using Cell®t (Becton-Dickinson) and Maccycle (Phoenix Flow Systems, Inc) programs, respectively.
Protein anlaysis
Immunoblotting and immunoprecipitation were carried out according to standard protocols (Sambrook et al., 1989) . For immunoblot analysis of whole cell extracts, culture medium was gently removed by aspiration, cells were collected by scraping in ice-cold PBS, pelleted and washed once with icecold PBS, and stored as frozen pellets at 7808C until use. Cells were lysed in hot (*808C) 26SDS sample buer [4% SDS, 20% glycerol, 150 mM Tris-HCl pH 6.8, 5 mM dithiotheitol (DTT), 1 mM sodium vanadate (Na 3 VO 4 ), boiled for 5 min and centrifuged at room temperature for 5 min. Protein concentrations in the supernatants were determined using the detergent-compatible protein assay kit (Bio Rad Laboratories, Inc). Protein aliquots were diluted to 16 by the addition of 1 mM Na 3 VO 4 , 5% 2-mercaptoethanol, and 0.01% bromophenol blue. Samples were fractionated on 10% SDS-polyacrylamide gels and transferred to nitrocellulose. The antibodies used were: polyclonal rabbit anti-mouse p34 cdc2 C-terminal antibody (0.11 mg/ml, UBI Inc), polyclonal rabbit anti-human p33 cdk2 (0.50 mg/ml, UBI Inc), mouse monoclonal anti-human cyclin B1 (0.26 mg/ml, UBI Inc), polyclonal rabbit anti-cyclin A antiserum (1 : 5000, gift from G Draetta), polyclonal rabbit anti-human cyclin D (0.4 mg/ml, UBI Inc), and rabbit polyclonal anti-cyclin E antiserum (1 : 5000, gift from M Ohtsubo and J Roberts) diluted in 1% milk/TBST. Binding of the antibodies was detected using an anti-rabbit or antimouse IgG horseradish peroxidase conjugated secondary antibody (Boehringer Mannheim) and visualized by enhanced chemiluminescence (Amersham).
For immunoprecipitations, cells were harvested as for immunoblotting but lysed in ice-cold kinase lysis buer [1% NP-40, 150 mM NaCl, 10 mM sodium phosphate pH 7.2, 1 mM EDTA, 5 mM EGTA] containing 5 mM b-glycerophosphate, 5 mM NaF, 2 mM phenylmethylsulfonyl¯uoride (PMSF), 2 mM dithiotheitol (DTT), 10 mg/ml leupeptin, 2 mg/ml aprotinin, and 1 mM Na 3 VO 4 . The lysates were clari®ed by centrifugation at 100 000 g for 1 h and the protein concentrations were determined as described above. For immunoprecipitation with speci®c antibodies, clari®ed extracts were preabsorbed for 30 min at 48C with 25 ml of protein G agarose (Life Technologies Inc) prior to incubation with speci®c antibodies or antiserum. Incubations were carried out for 2 ± 4 h at 48C followed by 30 min of incubation with 25 ml protein G agarose. Complexes were pelleted by brief centrifugation and washed three times with 1 ml of kinase lysis buer containing 2 mM PMSF and 1 mM Na 3 VO 4 . Washed complexes were used directly for in vitro histone H1 kinase reactions.
Histone H1 kinase assays
Histone H1 kinase reactions were performed using washed immune complexes as previously described (Zhou et al., 1992) . The kinase reactions were incubated at 308C for 15 min and stopped by the addition of an equal volume of 26SDS sample buer containing 5% 2-mercaptoethanol and 0.02% bromophenol blue. Half of the reaction was analysed by SDS ± PAGE (10%) and visualized by autoradiography. The incorporated radioactivity was determined by PhosphorImage analysis (Molecular Dynamics) of the dried gels.
Immuno¯uorescence
Cells growing on coverslips were serum starved for 48 h, followed by a 2 h incubation in the presence of 5'-bromo-2'-deoxyuridine (BrdU). As a positive control, exponentially growing NIH3T3 cells were incubated in the presence of BrdU for 2 h. Cells were ®xed in 7208C methanol for 6 min and allowed to air dry. Coverslips were rinsed brie¯y in PBS and preincubated for 1 h in blocking solution (10% goat serum and 3% bovine serum albumin in PBS). For the detection of the p34 cdc2 protein and BrdU incorporation into DNA, anti-p34 cdc2 C-terminal antibody (UBI, Inc) was diluted to 2.2 mg/ml in the solution containing anti-BrdU antibody and nuclease which was included within the cell proliferation kit (Amersham). Coverslips were incubated for 1 h in this solution and rinsed with PBS. Binding of the antibodies was detected using anti-rabbit IgG-Texas Red for p34 cdc2 and anti-mouse IgG-FITC (Jackson Immunoresearch Laboratories, Inc) for BrdU. The DNA dye 4',6-diamidino-2-phenylindole (DAPI, 0.05 mg/ml) was included in the secondary antibody solution to visualize the nuclei of all cells. Cells were viewed with a Zeiss Axiovert 35 microscope equipped with¯uorescence optics and the images were recorded on DX 400 Fujichome ®lm.
Construction and expression of inducible sense and antisense c-mos(P2A) cell lines A 1.0 kb HindIII c-mos(P2A) fragment from pTZMA+ (obtained from GF VandeWoude) was cloned in both orientations into the HindIII site of pMT-CB6+ (Choo et al., 1986) . The plasmid pTZMA+ contains a murine c-mos gene with a mutation in the 5' coding region that was generated during previous constructions and results in an alanine substitution for proline at amino acid position 2. Mutation of this residue has been shown to increase the stability of the Xenopus mos protein (Nishizawa et al., 1993) . NIH3T3 cells were electroporated with 15 mg of DNA and stable transfectants were selected using 400 mg/ ml G418. Individual clones were selected and analysed for Zn 2+ -inducible expression of sense and antisense cmos(P2A) mRNA by Northern blot analysis.
RNA analysis
Total RNA was isolated from exponentially growing or serum starved cells using the RNAzol TM B method (Cinna/ Biotecx Laboratories International Inc). Northern blot analysis was carried out using standard techniques (Ausubel et al., 1992) . p34 cdc2 mRNA was detected using a nick-translated 1.1 kb EcoRI fragment from a plasmid containing murine p34 cdc2 cDNA (gift from JL Corden). Relative amounts of RNA loaded on the gel were visualized by ethidium staining prior to transferring to nitrocellulose. The incorporated radioactivity was determined by PhosphorImage analysis (Molecular Dynamics) of the nitrocellulose ®lter. c-mos(P2A) mRNA was detected using a nick-translated 1.0 kb HindIII fragment from pTZMA+, and actin mRNA was detected using a nicktranslated human b-actin cDNA probe (Clontech).
